FDA Investigator Helen R Bester
Helen R Bester has conducted inspections on 84 sites in 2 countries as of 27 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
84
Last Inspection Date:
27 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with Helen R Bester:
Aaron P Wozniak,
Amanda L Evanco,
Amy A Johnson,
Amy H Ruble,
Anita R Michael,
Ann Marie Montemurro,
Annette A Ragosta,
Annette Melendez,
April R Bowen,
Arie C Menachem,
Babatunde D Babalola,
Barbara D Wright,
Barbara T Carmichael,
Bonita S Chester,
Brandon L Mariner,
Brandy D Brown,
Brentley S Collins,
Brian A Graves,
Burnell M Henry,
Calvin Foulks,
Cara M Minelli,
Carl E Lovrich,
Carol F Robinson,
Carol J Blackwood,
Chateryl K Washington,
Cheryl D Barton,
Christina H Owens,
Christopher J Adams,
Claudele S Razo,
Claudette D Brooks,
Cody D Rickman,
Cordelia J Brammer,
Cynthia Jim, CSO,
Dawn M Braswell,
Debra J Tucker,
Dellarese L Herbert,
Derek C Price,
Devaughn Edwards,
Dionne D Arline,
Doretha M Tonkins,
Doretha M Wilson,
Douglas F Frazier,
Dr. Gang Wang, PhD,
Edecia A Richards,
Edward Deberry,
Eileen J Bannerman,
Eliezar Ramos,
Ernest H Blackwood,
Esra Toussaint,
Eural E Porter,
Fabian Nchaparro Rodriguez,
Fulton A Varner,
Gail L Katz,
Gary E Coleman, Jr, REHS,
Gene D Arcy,
Helen B Ricalde,
Holly M Scott,
Hristu B Chepa,
Ibad U Khan,
Inga M Warr,
Jackie M Douglas,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
Jana L Caylor,
Janet B Gray,
Jessica Fields,
Joanne Pryzbylik,
Joe A Odom,
Jonathan G Matrisciano,
Julie D Bringger,
Karen A Coleman,
Kelley L Clark,
Kenneth L Smalls,
Kimberly Cdelk Brooks,
Kip J Hanks,
Latonya T Jiggetts,
Laurel A Beer,
LCDR Debra Emerson,
Leena Thomas,
Leslie W Gilbert,
Linda Thai,
Lorenzo Jones,
Lori A Holmquist,
Marian A Kainer,
Marion Michaelis,
Mariza M Jafary,
Marla A Cassidy,
Mary A Millner,
Mary Alice Papadimitriou,
Megan K Robinson,
Melanie M Walker,
Melanie W Pishnery,
Miaja Umaedi,
Michael R Goga,
Michelle D Haamid,
Mihaly S Ligmond,
Mizanne E Lewis,
Myla D Chapman,
Myoshi M Francis,
Nancy L Neiger,
Nawab A Siddiqui,
Nicholas M Smith,
Omotunde O Osunsanmi,
Pamela L Velez Vega,
Patricia F Hudson,
Paul A Bonneau,
Paul W Moy,
Paula A Trost,
Paula J Bretz,
Prabhu P Raju,
Randy L Clarida,
Rhonda Alexander,
Richard J Bashay,
Richard L Garcia,
Robert W Fisher,
Ronnie E Jackson,
Rose Ashley,
Russell R Zablan,
Sayeeda Hdabe,
Sharna D Pratt,
Sheryl A Kochman,
Shusheen A Alexander,
Shwnji Susie Lee,
Stardust W Mazzariello,
Stephanie E Hubbard,
Stephanie Harrell,
Stephen D Brown,
Steven D Banks,
Susan M Jackson,
Susan Yu,
Tammara A Stephens,
Thao Le,
Theressa B Smith,
Tracy R Ball,
Trang N Cox,
Valerie Jgrecek Trinh,
Vanessa E Coulter,
Vincent M Williams,
Wella Wang,
Xiomara Copeland
Helen R Bester's Documents
Publish Date | Document Type | Title |
---|---|---|
March, 2002 | EIR | Regenerative Biologics Inc. - EIR, 2002-03-21 |
April, 2002 | FDA 483 | Artivion, Inc - Form 483, 2002-04-12 |
April, 2002 | FDA 483 Response | Artivion, Inc - Form 483R, 2002-05-15 |
April, 2002 | EIR | Artivion, Inc - EIR, 2002-04-12 |
March, 2002 | FDA 483 Response | Regenerative Biologics Inc. - Form 483R, 2002-04-16 |
October, 2000 | FDA 483 | American National Red Cross (The) Carolinas Region - Form 483, 2000-07-26 |
March, 2002 | FDA 483 | Regenerative Biologics Inc. - Form 483, 2002-03-21 |
January, 2000 | FDA 483 | American Red Cross - Form 483, 2000-01-26 |
October, 2000 | FDA 483 | The American National Red Cross South Carolina Region - Form 483, 2000-08-18 |
October, 2002 | FDA 483 Response | Walter L. Shepeard Community Blood Center, Inc. - Form 483R, 2002-11-12 |
October, 2002 | FDA 483 | Walter L. Shepeard Community Blood Center, Inc. - Form 483, 2002-10-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more